Nereid Therapeutics
PrivateLast Round
Series A
Nov 16, 2020
Total Funding Raised
$50M
Company Overview
Nereid Therapeutics operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Series A round in November 2020.
Nereid Therapeutics is a biotechnology company that develops small molecule therapeutics for cancer, neurodegenerative disorders, and inflammatory diseases by leveraging proprietary technologies to study liquid-liquid phase separation and biomolecular condensates.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nereid Therapeutics Comparables
Compare Nereid Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Transition Bio | 92% | |
| Dewpoint Therapeutics | 91% | |
| Aquinnah Pharmaceuticals | 88% |
For institutional investors. Book with your work email.
Nereid Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Nereid Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Apple Tree Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 16, 2020
$50M round led by Apple Tree Partners
For institutional investors. Book with your work email.
Nereid Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nereid Therapeutics's valuation, stock price, and market status.
Is Nereid Therapeutics a public or private company?
Nereid Therapeutics is a private company.
What is the current stock price of Nereid Therapeutics?
Nereid Therapeutics is a private company, so its shares have no public market price. Caplight tracks Nereid Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nereid Therapeutics worth (valuation)?
Valuation information for Nereid Therapeutics is not publicly available.
Can I buy Nereid Therapeutics stock?
Nereid Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nereid Therapeutics's last funding round?
Nereid Therapeutics's most recent funding round was Series A on November 16, 2020.
Who are the main investors in Nereid Therapeutics?
Key investors in Nereid Therapeutics include Apple Tree Partners.
Will Nereid Therapeutics IPO soon?
No public IPO plans have been announced for Nereid Therapeutics.
How can I track Nereid Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Nereid Therapeutics's shares on secondary markets.